Engineered revision of the E. coli Nissle 1917 Genome

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: 1R43GM079052-01A2
Agency Tracking Number: GM079052
Amount: $141,037.00
Phase: Phase I
Program: SBIR
Awards Year: 2008
Solicitation Year: 2008
Solicitation Topic Code: N/A
Solicitation Number: PHS2007-2
Small Business Information
SCARAB GENOMICS, LLC, 1547 JEFFERSON ST, MADISON, WI, 53711
DUNS: 105975036
HUBZone Owned: Y
Woman Owned: Y
Socially and Economically Disadvantaged: Y
Principal Investigator
 FREDERICK BLATTNER
 (608) 890-0191
 FRED@GENOME.WISC.EDU
Business Contact
Phone: (608) 257-1624
Email: fredblattner@scarabgenomics.com
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): The ability of genetically modified probiotic (beneficial) bacteria to deliver therapeutic compounds is a promising new experimental method for delivering fragile and complex bio-molecules without injection. The long-t erm goal of this study is to improve the genetic stability of a probiotic organism for use as a living drug delivery vehicle. Escherichia coli Nissle 1917, a non-pathogenic E. coli, currently used in probiotic treatment of intestinal disorders, is an attra ctive candidate drug delivery system. Although recombinant DNA methods were originally pioneered in E. coli and this organism remains the most common host for bacterial production of recombinant products, some problems still occur. Degradation of strain pe rformance is not unusual in industrial fermentations and is often the result of genetic instability due to mobile elements originating from the bacterial chromosome. This proposal outlines a program for removing mobile elements from the E. coli Nissle 1917 chromosome using well characterized recombination methods. Sequences to be deleted are chosen on the basis of their similarity to regions in pathogenic E. coli, the presence of many mobile elements and identifiable prophage sequences and similarity to gen es that will be used in therapeutic applications of this strain. The primary goal of the proposed research program is to produce variants of E. coli Nissle 1917 that lack all pathogenic and mobile genetic elements. Individual deletion strains will be teste d for viability and their ability to persist in the mouse gut. Deletion strains that exhibit no loss of viability or persistence will be noted and the deletions cumulatively combined. Deletion strains with diminished viability or persistence will serve as hosts for gene addition studies, to determine which genes are required to restore viability and/or persistence.

* Information listed above is at the time of submission. *

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government